Explain this page
Arphra AIPlain-English read on Ionis Pharmaceuticals, Inc.’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $107.27 (+44.03%)
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.87% | -1.57% | -2.03% | +0.59% | -8.81% | -5.85% | +102.61% | +83.67% | +107.64% | +233.54% | +644.80% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$73.48
Bid
$70.11
25 sh
Ask
$78.00
90 sh
Spread
$7.890
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- Ionis Pharmaceuticals, Inc. (IONS) Discusses Progress in RNA Therapeutics and Transition to Commercial-Stage Biotechnology Transcriptseekingalpha.com·Jun 05, 2026
- Ionis to present new analyses from CORE and CORE2 pivotal studies supporting olezarsen for severe hypertriglyceridemia (sHTG) at upcoming congressesbusinesswire.com·Jun 04, 2026
- Ionis to present new analyses from CORE and CORE2 pivotal studies supporting olezarsen for severe hypertriglyceridemia (sHTG) at upcoming congressesbusinesswire.com·Jun 04, 2026
- Ionis Pharmaceuticals, Inc. (IONS) Presents at Bank of America Global Healthcare Conference 2026 Transcriptseekingalpha.com·May 12, 2026
- Ionis to host 2026 virtual Annual Meeting of Stockholdersbusinesswire.com·May 04, 2026
- Ionis to host 2026 virtual Annual Meeting of Stockholdersbusinesswire.com·May 04, 2026
- Ionis to present at upcoming investor conferencesbusinesswire.com·May 01, 2026
Peers
No peer list available for IONS.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|